Glaxosmithkline Pharma standalone net profit rises 3.45% in the September 2016 quarter

Sales rise 11.85% to Rs 782.86 crore

Net profit of Glaxosmithkline Pharma rose 3.45% to Rs 98.85 crore in the quarter ended September 2016 as against Rs 95.55 crore during the previous quarter ended September 2015. Sales rose 11.85% to Rs 782.86 crore in the quarter ended September 2016 as against Rs 699.95 crore during the previous quarter ended September 2015. ParticularsQuarter EndedSep. 2016Sep. 2015% Var.Sales782.86699.95 12 OPM %17.9818.30 -PBDT158.82159.44 0 PBT152.24154.11 -1 NP98.8595.55 3

Powered by Capital Market - Live News